Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SynthelabofiledCriticalSanofi Synthelabo
Publication of UY25339A1publicationCriticalpatent/UY25339A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La presente invención se refiere a la utilización de un compuesto de 1-(2-flofluorofenil)-3-(4-hidroxifenil)-prop-2-en-1-ona-O-2-dimetilamino etil)-oxima de fórmula l, para la preparación de medicamentos útiles en el tratamiento del síndrome de la apnea del sueño, en particular, el síndrome de la apnea-hiponea obstructiva del sueño. Preparación de medicamentos para la administración oral.The present invention relates to the use of a 1- (2-flofluorophenyl) -3- (4-hydroxyphenyl) -prop-2-en-1-one-O-2-dimethylamino ethyl) -oxime compound of formula l , for the preparation of drugs useful in the treatment of sleep apnea syndrome, in particular the obstructive sleep apnea-hypona syndrome. Preparation of drugs for oral administration.
UY25339A1998-11-111999-01-08
PROCEDURE FOR THE PREPARATION OF MEDICINES CONTAINING COMPOUNDS USED IN THE TREATMENT OF SLEEP APNEA SYNDROME.
UY25339A1
(en)
Substituted morpholine and thiomorpholine derivatives, pharmaceutical composition based thereon and use thereof for the preparation of medicament for the treatment of a disorder or disease of the central nervous system
Compound, process for the preparation of a compound, pharmaceutical composition comprising the compound, use of the compound, process for the treatment and prophylaxis of disorders and for the treatment of obesity.
Compound, use of a compound, disorder treatment process, compound preparation process, pharmaceutical composition comprising the compound and obesity treatment process
Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on a disturbance of NO production and / or regulation of EDHF function.